Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second Phase of "Carotid RX ACCULINK/RX ACCUNET Post-Approval Trial to Uncover Unanticipated or Rare Events"

NCT00302237 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT00302237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00302237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second Phase of "Carotid RX ACCULINK/RX ACCUNET Post-Approval Trial to Uncover Unanticipated or Rare Events"
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
March 31, 2006
Completion date
May 31, 2010
Enrollment
6,426 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carotid artery disease